January 10, 2006
Tranzyme Pharma Receives IND Clearance for its Novel Ghrelin Agonist, TZP-101

November 14, 2005
Tranzyme Licenses its Trans-Lentiviral Vector Technology to Open Biosystems
September 20, 2005
Tranzyme Pharma Appoints New Vice President of Clinical and Regulatory Affairss

Click to listen to Wall Street Reporter interview with Vipin Garg about the latest financing.